Treatment against glucose-dependent cancers through metabolic PFKFB3 targeting of glycolytic flux.
Saved in:
| Title: | Treatment against glucose-dependent cancers through metabolic PFKFB3 targeting of glycolytic flux. |
|---|---|
| Authors: | Jones BC; Department of Oncology, Georgetown Lombardi Comprehensive Cancer Center, 3970 Reservoir Rd NW, Washington, DC, 20057, USA., Pohlmann PR; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1354, Houston, TX, 77030, USA., Clarke R; The Hormel Institute, University of Minnesota, 801 16th Ave NE, Austin, MN, 55912, USA., Sengupta S; The Hormel Institute, University of Minnesota, 801 16th Ave NE, Austin, MN, 55912, USA. ssengupt@umn.edu. |
| Source: | Cancer metastasis reviews [Cancer Metastasis Rev] 2022 Jun; Vol. 41 (2), pp. 447-458. Date of Electronic Publication: 2022 Apr 14. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8605731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7233 (Electronic) Linking ISSN: 01677659 NLM ISO Abbreviation: Cancer Metastasis Rev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-7233 |
|---|---|
| DOI: | 10.1007/s10555-022-10027-5 |
